1.https://www.who.int/health-topics/diabetes
2.https://www.cdc.gov/diabetes/library/spotlights/diabetes-facts-stats.html
With an innovative combination of several novel optical sensors and multi-layered artificial intelligence with the ability to adapt and personalize, we have been able to create a highly functional and highly accurate device for diabetic patients. We have been testing this technology for more than 2 years in an accredited laboratory with more than 7,000 diabetic patients, improving its accuracy and patenting it in the United States.
By using high-resolution sensors, the blood that passes through the fingertips is continuously monitored, by measuring important blood factors and creating a meaningful relationship between them, blood glucose is calculated with high accuracy with the help of the artificial intelligence of the device. (Patent Pending)
Many companies in the world are looking to realize the dream of non-invasive blood glucose monitoring. Our advantage over competitors is the use of a new combination of sensors with multi-layered artificial intelligence. We have been able to achieve this combination of sensors and artificial intelligence with clinical tests on diabetic patients in two years and patent it.
Since we use several sensors with different characteristics and different wavelengths,(unlike our competitors), we can also work on other blood factors and effective factors on diabetic patients so in the next steps to create an unrivaled market for our product, so that diabetic patients do not need to use other devices.
Copyright © 2024 GLYCOSA - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.